Correlation between BRAF mutation and promoter methylation of TIMP3, RARβ2 and RASSF1A in thyroid cancer

References

• Esteller M. Epigenetics in cancer. N Engl J Med 2008; 358:1148 - 59; http://dx.doi.org/10.1056/NEJMra072067; PMID: 18337604
   PubMed Web of Science ®Google Scholar
• Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003; 349:2042 - 54; http://dx.doi.org/10.1056/NEJMra023075; PMID: 14627790
   PubMed Web of Science ®Google Scholar
• Cohen Y, Xing M, Mambo E, Guo Z, Wu G, Trink B, et al. BRAF mutation in papillary thyroid carcinoma. J Natl Cancer Inst 2003; 95:625 - 7; http://dx.doi.org/10.1093/jnci/95.8.625; PMID: 12697856
   PubMed Web of Science ®Google Scholar
• Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res 2003; 63:1454 - 7; PMID: 12670889
   PubMed Web of Science ®Google Scholar
• Wan PT, Garnett MJ, Roe SM, Lee S, Niculescu-Duvaz D, Good VM, et al, Cancer Genome Project. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell 2004; 116:855 - 67; http://dx.doi.org/10.1016/S0092-8674(04)00215-6; PMID: 15035987
   PubMed Web of Science ®Google Scholar
• Hoque MO, Rosenbaum E, Westra WH, Xing M, Ladenson P, Zeiger MA, et al. Quantitative assessment of promoter methylation profiles in thyroid neoplasms. J Clin Endocrinol Metab 2005; 90:4011 - 8; http://dx.doi.org/10.1210/jc.2005-0313; PMID: 15840741
   PubMed Web of Science ®Google Scholar
• Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001; 61:3225 - 9; PMID: 11309270
   PubMed Web of Science ®Google Scholar
• Hoque MO, Kim MS, Ostrow KL, Liu J, Wisman GB, Park HL, et al. Genome-wide promoter analysis uncovers portions of the cancer methylome. Cancer Res 2008; 68:2661 - 70; http://dx.doi.org/10.1158/0008-5472.CAN-07-5913; PMID: 18413733
   PubMed Web of Science ®Google Scholar
• Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996; 93:9821 - 6; http://dx.doi.org/10.1073/pnas.93.18.9821; PMID: 8790415
   PubMed Web of Science ®Google Scholar
• Suzuki H, Gabrielson E, Chen W, Anbazhagan R, van Engeland M, Weijenberg MP, et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 2002; 31:141 - 9; http://dx.doi.org/10.1038/ng892; PMID: 11992124
   PubMed Web of Science ®Google Scholar
• Ishida E, Nakamura M, Shimada K, Higuchi T, Takatsu K, Yane K, et al. DNA hypermethylation status of multiple genes in papillary thyroid carcinomas. Pathobiology 2007; 74:344 - 52; http://dx.doi.org/10.1159/000110028; PMID: 18087199
   PubMed Web of Science ®Google Scholar
• Smith JA, Fan CY, Zou C, Bodenner D, Kokoska MS. Methylation status of genes in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 2007; 133:1006 - 11; http://dx.doi.org/10.1001/archotol.133.10.1006; PMID: 17938324
   PubMed Web of Science ®Google Scholar
• Xing M, Usadel H, Cohen Y, Tokumaru Y, Guo Z, Westra WB, et al. Methylation of the thyroid-stimulating hormone receptor gene in epithelial thyroid tumors: a marker of malignancy and a cause of gene silencing. Cancer Res 2003; 63:2316 - 21; PMID: 12727856
   PubMed Web of Science ®Google Scholar
• Guan H, Ji M, Hou P, Liu Z, Wang C, Shan Z, et al. Hypermethylation of the DNA mismatch repair gene hMLH1 and its association with lymph node metastasis and T1799A BRAF mutation in patients with papillary thyroid cancer. Cancer 2008; 113:247 - 55; http://dx.doi.org/10.1002/cncr.23548; PMID: 18470905
   PubMed Web of Science ®Google Scholar
• Huang Y, de la Chapelle A, Pellegata NS. Hypermethylation, but not LOH, is associated with the low expression of MT1G and CRABP1 in papillary thyroid carcinoma. Int J Cancer 2003; 104:735 - 44; http://dx.doi.org/10.1002/ijc.11006; PMID: 12640681
   PubMed Web of Science ®Google Scholar
• Hu S, Liu D, Tufano RP, Carson KA, Rosenbaum E, Cohen Y, et al. Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer. Int J Cancer 2006; 119:2322 - 9; http://dx.doi.org/10.1002/ijc.22110; PMID: 16858683
   PubMed Web of Science ®Google Scholar
• Nakamura N, Carney JA, Jin L, Kajita S, Pallares J, Zhang H, et al. RASSF1A and NORE1A methylation and BRAFV600E mutations in thyroid tumors. Lab Invest 2005; 85:1065 - 75; http://dx.doi.org/10.1038/labinvest.3700306; PMID: 15980887
   PubMed Web of Science ®Google Scholar
• Bello MJ, De Campos JM, Isla A, Casartelli C, Rey JA. Promoter CpG methylation of multiple genes in pituitary adenomas: frequent involvement of caspase-8. Oncol Rep 2006; 15:443 - 8; PMID: 16391867
   PubMed Web of Science ®Google Scholar
• Xing M, Cohen Y, Mambo E, Tallini G, Udelsman R, Ladenson PW, et al. Early occurrence of RASSF1A hypermethylation and its mutual exclusion with BRAF mutation in thyroid tumorigenesis. Cancer Res 2004; 64:1664 - 8; http://dx.doi.org/10.1158/0008-5472.CAN-03-3242; PMID: 14996725
   PubMed Web of Science ®Google Scholar
• Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, et al. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 2000; 28:E32; http://dx.doi.org/10.1093/nar/28.8.e32; PMID: 10734209
   PubMed Web of Science ®Google Scholar
• Virmani AK, Tsou JA, Siegmund KD, Shen LY, Long TI, Laird PW, et al. Hierarchical clustering of lung cancer cell lines using DNA methylation markers. Cancer Epidemiol Biomarkers Prev 2002; 11:291 - 7; PMID: 11895880
   PubMed Web of Science ®Google Scholar
• de Bernard S, Misrahi M, Huet JC, Beau I, Desroches A, Loosfelt H, et al. Sequential cleavage and excision of a segment of the thyrotropin receptor ectodomain. J Biol Chem 1999; 274:101 - 7; http://dx.doi.org/10.1074/jbc.274.1.101; PMID: 9867816
   PubMed Web of Science ®Google Scholar
• Reddy AN, Jiang WW, Kim M, Benoit N, Taylor R, Clinger J, et al. Death-associated protein kinase promoter hypermethylation in normal human lymphocytes. Cancer Res 2003; 63:7694 - 8; PMID: 14633692
   PubMed Web of Science ®Google Scholar
• Brait M, Ford JG, Papaiahgari S, Garza MA, Lee JI, Loyo M, et al. Association between lifestyle factors and CpG island methylation in a cancer-free population. Cancer Epidemiol Biomarkers Prev 2009; 18:2984 - 91; http://dx.doi.org/10.1158/1055-9965.EPI-08-1245; PMID: 19861513
   PubMed Web of Science ®Google Scholar
• Feil R. Environmental and nutritional effects on the epigenetic regulation of genes. Mutat Res 2006; 600:46 - 57; http://dx.doi.org/10.1016/j.mrfmmm.2006.05.029; PMID: 16854438
   PubMed Web of Science ®Google Scholar
• Herceg Z. Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors. Mutagenesis 2007; 22:91 - 103; http://dx.doi.org/10.1093/mutage/gel068; PMID: 17284773
   PubMed Web of Science ®Google Scholar
• Jerónimo C, Henrique R, Hoque MO, Mambo E, Ribeiro FR, Varzim G, et al. A quantitative promoter methylation profile of prostate cancer. Clin Cancer Res 2004; 10:8472 - 8; http://dx.doi.org/10.1158/1078-0432.CCR-04-0894; PMID: 15623627
   PubMed Web of Science ®Google Scholar
• Burbee DG, Forgacs E, Zöchbauer-Müller S, Shivakumar L, Fong K, Gao B, et al. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst 2001; 93:691 - 9; http://dx.doi.org/10.1093/jnci/93.9.691; PMID: 11333291
   PubMed Web of Science ®Google Scholar
• Ibanez de Caceres I, Battagli C, Esteller M, Herman JG, Dulaimi E, Edelson MI, et al. Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patients. Cancer Res 2004; 64:6476 - 81; http://dx.doi.org/10.1158/0008-5472.CAN-04-1529; PMID: 15374957
   PubMed Web of Science ®Google Scholar
• Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 2000; 25:315 - 9; http://dx.doi.org/10.1038/77083; PMID: 10888881
   PubMed Web of Science ®Google Scholar
• Khokhlatchev A, Rabizadeh S, Xavier R, Nedwidek M, Chen T, Zhang XF, et al. Identification of a novel Ras-regulated proapoptotic pathway. Curr Biol 2002; 12:253 - 65; http://dx.doi.org/10.1016/S0960-9822(02)00683-8; PMID: 11864565
   PubMed Web of Science ®Google Scholar
• Ortiz-Vega S, Khokhlatchev A, Nedwidek M, Zhang XF, Dammann R, Pfeifer GP, et al. The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1. Oncogene 2002; 21:1381 - 90; http://dx.doi.org/10.1038/sj.onc.1205192; PMID: 11857081
   PubMed Web of Science ®Google Scholar
• Vos MD, Ellis CA, Bell A, Birrer MJ, Clark GJ. Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis. J Biol Chem 2000; 275:35669 - 72; http://dx.doi.org/10.1074/jbc.C000463200; PMID: 10998413
   PubMed Web of Science ®Google Scholar
• Mehlen P, Rabizadeh S, Snipas SJ, Assa-Munt N, Salvesen GS, Bredesen DE. The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature 1998; 395:801 - 4; http://dx.doi.org/10.1038/27441; PMID: 9796814
   PubMed Web of Science ®Google Scholar
• Lo KW, Kwong J, Hui AB, Chan SY, To KF, Chan AS, et al. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res 2001; 61:3877 - 81; PMID: 11358799
   PubMed Web of Science ®Google Scholar
• Niwa T, Tsukamoto T, Toyoda T, Mori A, Tanaka H, Maekita T, et al. Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells. Cancer Res 2010; 70:1430 - 40; http://dx.doi.org/10.1158/0008-5472.CAN-09-2755; PMID: 20124475
   PubMed Web of Science ®Google Scholar
• Brait M, Begum S, Carvalho AL, Dasgupta S, Vettore AL, Czerniak B, et al. Aberrant promoter methylation of multiple genes during pathogenesis of bladder cancer. Cancer Epidemiol Biomarkers Prev 2008; 17:2786 - 94; http://dx.doi.org/10.1158/1055-9965.EPI-08-0192; PMID: 18843024
   PubMed Web of Science ®Google Scholar
• Shivakumar L, Minna J, Sakamaki T, Pestell R, White MA. The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol Cell Biol 2002; 22:4309 - 18; http://dx.doi.org/10.1128/MCB.22.12.4309-4318.2002; PMID: 12024041
   PubMed Web of Science ®Google Scholar
• Hu S, Ewertz M, Tufano RP, Brait M, Carvalho AL, Liu D, et al. Detection of serum deoxyribonucleic acid methylation markers: a novel diagnostic tool for thyroid cancer. J Clin Endocrinol Metab 2006; 91:98 - 104; http://dx.doi.org/10.1210/jc.2005-1810; PMID: 16263813
   PubMed Web of Science ®Google Scholar
• Jen J, Harper JW, Bigner SH, Bigner DD, Papadopoulos N, Markowitz S, et al. Deletion of p16 and p15 genes in brain tumors. Cancer Res 1994; 54:6353 - 8; PMID: 7987828
   PubMed Web of Science ®Google Scholar
• Gozuacik D, Bialik S, Raveh T, Mitou G, Shohat G, Sabanay H, et al. DAP-kinase is a mediator of endoplasmic reticulum stress-induced caspase activation and autophagic cell death. Cell Death Differ 2008; 15:1875 - 86; http://dx.doi.org/10.1038/cdd.2008.121; PMID: 18806755
   PubMed Web of Science ®Google Scholar
• Li GM, Modrich P. Restoration of mismatch repair to nuclear extracts of H6 colorectal tumor cells by a heterodimer of human MutL homologs. Proc Natl Acad Sci U S A 1995; 92:1950 - 4; http://dx.doi.org/10.1073/pnas.92.6.1950; PMID: 7892206
   PubMed Web of Science ®Google Scholar
• Bolderson E, Scorah J, Helleday T, Smythe C, Meuth M. ATM is required for the cellular response to thymidine induced replication fork stress. Hum Mol Genet 2004; 13:2937 - 45; http://dx.doi.org/10.1093/hmg/ddh316; PMID: 15459181
   PubMed Web of Science ®Google Scholar
• Carvalho AL, Jeronimo C, Kim MM, Henrique R, Zhang Z, Hoque MO, et al. Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma. Clin Cancer Res 2008; 14:97 - 107; http://dx.doi.org/10.1158/1078-0432.CCR-07-0722; PMID: 18172258
   PubMed Web of Science ®Google Scholar
• Benoit NE, Goldenberg D, Deng SX, Rosenbaum E, Cohen Y, Califano JA, et al. Colorimetric approach to high-throughput mutation analysis. Biotechniques 2005; 38:635 - 9; http://dx.doi.org/10.2144/05384PF01; PMID: 15884682
   PubMed Web of Science ®Google Scholar
• SAS/STAT Users Guide. Cary: SAS Institute Inc., 1999.
   Google Scholar